68 related articles for article (PubMed ID: 38346068)
1. Poor clinical outcomes and immunoevasive contexture in CD161
Chen Q; Yin H; Jiang Z; He T; Xie Y; Mao W; Han J; Liu S; Lou W; Wu W; Habib JR; Yu J; Liu L; Pu N
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38531664
[TBL] [Abstract][Full Text] [Related]
2. Characterization of natural killer and cytotoxic T-cell immune infiltrates in pancreatic ductal adenocarcinoma.
Persky J; Cruz SM; Darrow MA; Judge SJ; Li Y; Bold RJ; Karnezis AN; Matsukuma KE; Qi L; Canter RJ
J Surg Oncol; 2024 Apr; 129(5):885-892. PubMed ID: 38196111
[TBL] [Abstract][Full Text] [Related]
3. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis.
Karneris A; Dedeilia A; Boland GM
Ann Surg Oncol; 2024 Jan; 31(1):16-18. PubMed ID: 37814185
[No Abstract] [Full Text] [Related]
4. Deficiency in infiltration of CD8/CD3 positive lymphocytes and macrophages plays a role in lip carcinogenesis: an immunohistochemical study.
Magalhães IA; Costa GAJ; Borges MMF; Carlos ACAM; Mesquita KC; Arruda LMA; Cunha MDPSS; Sousa FB; Silva PGB
Braz J Otorhinolaryngol; 2024; 90(2):101379. PubMed ID: 38219446
[TBL] [Abstract][Full Text] [Related]
5. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
[TBL] [Abstract][Full Text] [Related]
6. Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.
Tushoski-Alemán GW; Herremans KM; Underwood PW; Akki A; Riner AN; Trevino JG; Han S; Hughes SJ
PLoS One; 2024; 19(2):e0297325. PubMed ID: 38346068
[TBL] [Abstract][Full Text] [Related]
7. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
[TBL] [Abstract][Full Text] [Related]
8. The association between CD3
Panahi M; Rezagholizadeh F; Mollazadehghomi S; Farhangnia P; Niya MHK; Ajdarkosh H; Tameshkel FS; Heshmati SM
Cancer Treat Res Commun; 2023; 35():100699. PubMed ID: 36996584
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma.
Lohneis P; Sinn M; Bischoff S; Jühling A; Pelzer U; Wislocka L; Bahra M; Sinn BV; Denkert C; Oettle H; Bläker H; Riess H; Jöhrens K; Striefler JK
Eur J Cancer; 2017 Sep; 83():290-301. PubMed ID: 28772128
[TBL] [Abstract][Full Text] [Related]
10. Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma.
Mahajan UM; Langhoff E; Goni E; Costello E; Greenhalf W; Halloran C; Ormanns S; Kruger S; Boeck S; Ribback S; Beyer G; Dombroswki F; Weiss FU; Neoptolemos JP; Werner J; D'Haese JG; Bazhin A; Peterhansl J; Pichlmeier S; Büchler MW; Kleeff J; Ganeh P; Sendler M; Palmer DH; Kohlmann T; Rad R; Regel I; Lerch MM; Mayerle J
Gastroenterology; 2018 Nov; 155(5):1625-1639.e2. PubMed ID: 30092175
[TBL] [Abstract][Full Text] [Related]
11. C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer.
Sasaki K; Takano S; Tomizawa S; Miyahara Y; Furukawa K; Takayashiki T; Kuboki S; Takada M; Ohtsuka M
J Exp Clin Cancer Res; 2021 Jun; 40(1):212. PubMed ID: 34167573
[TBL] [Abstract][Full Text] [Related]
12. IL-1β
Caronni N; La Terza F; Vittoria FM; Barbiera G; Mezzanzanica L; Cuzzola V; Barresi S; Pellegatta M; Canevazzi P; Dunsmore G; Leonardi C; Montaldo E; Lusito E; Dugnani E; Citro A; Ng MSF; Schiavo Lena M; Drago D; Andolfo A; Brugiapaglia S; Scagliotti A; Mortellaro A; Corbo V; Liu Z; Mondino A; Dellabona P; Piemonti L; Taveggia C; Doglioni C; Cappello P; Novelli F; Iannacone M; Ng LG; Ginhoux F; Crippa S; Falconi M; Bonini C; Naldini L; Genua M; Ostuni R
Nature; 2023 Nov; 623(7986):415-422. PubMed ID: 37914939
[TBL] [Abstract][Full Text] [Related]
13. A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma.
Herremans KM; Underwood PW; Riner AN; Neal DW; Tushoski-Alemán GW; Forsmark CE; Nassour I; Han S; Hughes SJ
Pancreatology; 2023 Sep; 23(6):615-621. PubMed ID: 37391359
[TBL] [Abstract][Full Text] [Related]
14. Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8
LaPorte KM; Hernandez R; Santos Savio A; Malek TR
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37270181
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
